Form 4 for BOLT Bolt Biotherapeutics, Inc.
Accepted 2025-10-24 00:00:00 ET · period of report 2025-10-24 · accession 0001193125-25-250334 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-10-24 | 2025-10-22 | BOLT | Nemec Sarah | Senior VP, Fin, PAO | A - Grant | $0.00 | +23.0K | 23.9K | +2,439% | $0 | |
| 2025-10-24 | 2025-06-06 | BOLT | Nemec Sarah | Senior VP, Fin, PAO | P - Purchase | $5.49 | +125 | 943 | +15% | +$686.25 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-10-22 | A | A | 23,000 | $0.00 | 23,943 | D | — | — | (F2) The shares represent restricted stock units that were received as an award, for no consideration. Each restricted stock unit represents the right to receive, at settlement, one share of common stock. |
| 2 | Common | Common Stock | 2025-06-06 | P | A | 125 | $5.49 | 943 | D | — | — | (F1) Shares acquired under the issuer's Employee Stock Purchase Plan and therefore exempt under Rule 16b-3(c) |